Association between hepatitis B surface antibody seropositivity and coronary artery disease

Indian Journal of Medical Sciences

Volumn 61, Issue 12, 2007, Pages 648-655

  Amirzadegan, Alireza ^a   Davoodi, Gholamreza ^a   Boroumand, Mohammad ^a   Darabyan, Sirous ^a   Dehkordi, Maria ^a   Goodarzynejad, Hamidreza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

C reactive protein; Coronary artery disease; Hepatitis B surface antibody; Infection; Inflammation

Indexed keywords

C REACTIVE PROTEIN; HEPATITIS B SURFACE ANTIBODY;

ADULT; AGED; ANGIOCARDIOGRAPHY; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREVALENCE; RISK FACTOR; SEROLOGY; VIRUS DETECTION; VIRUS HEPATITIS;

EID: 38149124192     PISSN: 00195359     EISSN: None     Source Type: Journal    
DOI: 10.4103/0019-5359.37785     Document Type: Article

References (25)

1. Futterman LG, Lemberg L. Fifty percent of patients with coronary artery disease do not have any of the conventional risk factors. Am J Crit Care 1998;7:240-4.
2. Hansson GK. Inflammation, atherosclerosis and coronary artery disease. N Engl J Med 2005;352:1685-95.
3. Laroia ST, Ganti AK, Potti A. Role of infections in atherogenesis. Indian Heart J 2003;55:27-34.
4. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, et al.. Low grade inflammation and coronary heart disease: Prospective study and updated meta-analyses. BMJ 2000;321:199-204.
5. Muhlestein JB. Chronic infection and coronary artery disease. Med Clin North Am 2000;84:123-48.
6. Sinha N, Garg N. Role of infections in the pathogenesis of atherosclerotic coronary artery disease: Past, present and future. Indian Heart J 2000;52:79-85.
7. Goyal P, Kalek SC, Chaudhry R, Chauhan S, Shah N. Association of common chronic infections with coronary artery disease in patients without any conventional risk factors. Indian J Med Res 2007;125:129-36.
8. Vijayvergiya R, Agarwal N, Bahl A, Grover A, Singh M, Sharma M, et al.. Association of Chlamydia pneumoniae and Helicobacter pylori infection with angiographically demonstrated coronary artery disease. Int J Cardiol 2006;107:428-9.
9. Bloemenkamp DG, Mali WP, Visseren FL, van der Graaf Y. Meta-analysis of seroepidemiologic studies of the relation between Chlamydia pneumoniae and atherosclerosis: Does study design influence results? Am Heart J 2003;145:409-17.
10. Danesh J. Coronary heart disease, Helicobacter pylori, dental disease, Chlamydia pneumoniae and cytomegalovirus: Meta-analyses of prospective studies. Am Heart J 1999;138:S434-7. 11. Momiyama Y, Ohmori R, Taniguchi H, Nakamura H, Ohsuzu F. Association of Mycoplasma pneumoniae infection with coronary artery disease and its interaction with chlamydial infection. Atherosclerosis 2004;176:139-44.
11. Perumal V, Mathai E, Jose J, Gupta S. Prevalence of Chlamydia pneumoniae IgG antibodies in patients with coronary artery disease: A report from an Indian population. Indian Heart J 2003;55:667.
12. Horvath R, Cerny J, Benedik J, Hokl J Jr, Jelinkova I, Benedik J. The possible role of human cytomegalovirus (HCMV) in the origin of atherosclerosis. J Clin Virol 2000;16:17-24.
13. Fong IW. Emerging relations between infectious diseases and coronary artery disease and atherosclerosis. CMAJ 2000;163:49-56.
14. Haraszthy VI, Zambon JJ, Trevisan M, Zied M, Genco RJ. Identification of periodontal pathogens in atheromatous plaques. J Periodontol 2000;71:1554-60.
15. Yetkin G. Is seropositivity enough to show the association between coronary artery disease and Chlamydia pneumoniae and Helicobacter pylori infection? Int J Cardiol 2006;113:432-4.
16. Ishizaka N, Ishizaka Y, Takahashi E, Tooda E, Hashimoto H, Nagai R, et al.. Association between hepatitis C virus seropositivity, carotid-artery plaque and intima-media thickening. Lancet 2002;359:133-5.
17. Ishizaka N, Ishizaka Y, Takahashi E, Toda Ei E, Hashimoto H, Ohno M, et al.. Increased prevalence of carotid atherosclerosis in hepatitis B virus carriers. Circulation 2002;105:1028-30.
18. Völzke H, Schwahn C, Wolff B, Mentel R, Robinson DM, Kleine V, et al.. Hepatitis B and C virus infection and the risk of atherosclerosis in a general population. Atherosclerosis 2004;174:99-103.
19. Kiechl S, Egger G, Mayr M, Wiedermann CJ, Bonora E, Oberhollenzer F, et al. Chronic infections and the risk of carotid atherosclerosis: Prospective results from a large population study. Circulation 2001;103:1064-70.
20. Bilora F, Rinaldi R, Boccioletti V, Petrobelli F, Girolami A. Chronic viral hepatitis: A prospective factor against atherosclerosis: A study with echo-color Doppler of the carotid and femoral arteries and the abdominal aorta. Gastroenterol Clin Biol 2002;26:1001-4.
21. WHO Consultation Definition, diagnosis and classification of diabetes mellitus and its complications, Part 1: Diagnosis and classification of diabetes mellitus. World Health Organisation: Geneva; 1999.
22. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983;51:606.
23. Rohde LE, Hennekens CH, Ridker PM. Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men. Am J Cardiol 1999;84:1018-22.
24. Tong DY, Wang XH, Xu CF, Yang YZ, Xiong SD. Hepatitis B virus infection and coronary atherosclerosis: Results from a population with relatively high prevalence of hepatitis B virus. World J Gastroenterol 2005;11:1292-6.
25. Bréchot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Bréchot P. Persistent hepatitis B infection in subjects without hepatitis B surface antigen: Clinically significant or purely occult? Hepatology 2001;34:194-203.